24Sep

New AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC

As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing. 

The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.


Download the whitepaper to learn:

  • How the body responds to SARS-COV-2
  • The different approaches to antibody testing
  • The UK-RTC Abc-19 Rapid Test
  • The link between antibodies and immunity
  • The route towards therapies and immunisation 

Please access the complete whitepaper for this device here.

Related

North East Innovation Lab receives investment of £1.4m to continue vital work to protect health

The North East Innovation Lab, originally established as part of the region’s integrated Covid hub,...

Read More >

SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, AUSTRALIA – (April 19, 2018). SpeeDx’s ResistancePlus® MG Positive Control kit has now bee...

Read More >

EKF signs DiaSpect Tm U.S. distribution agreement with McKesson to launch McKesson Consult® Hb analyzer

FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most esta...

Read More >

Cytox awarded new Innovate UK funding for Alzheimer’s disease testing

8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing geneti...

Read More >

BioIVT Acquires Commercial Blood Bank Tennessee Blood Services

Transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood,...

Read More >

Helping You Stay Comfortable and COVID Secure

New Range of CE Certified Face Visors and Type II Masks with Introductory 10% Savings

Read More >